Similar articles for PMID: 26659341

Year	Number of Results
2007	3
2008	11
2009	29
2010	11
2011	12
2012	10
2013	7
2014	7
2015	3
2016	7
2017	11
2018	7
2019	4
2020	13
2021	16
2022	12
2023	1

1

Gadolinium-Based Contrast Agent Accumulation and Toxicity: An Update.

Ramalho J, Semelka RC, Ramalho M, Nunes RH, AlObaidy M, Castillo M. Ramalho J, et al. AJNR Am J Neuroradiol. 2016 Jul;37(7):1192-8. doi: 10.3174/ajnr.A4615. Epub 2015 Dec 10. AJNR Am J Neuroradiol. 2016. PMID: 26659341 Free PMC article. Review.

2

Free gadolinium is a likely trigger of nephrogenic systemic fibrosis.

Abraham JL, Edward M. Abraham JL, et al. AJR Am J Roentgenol. 2009 Oct;193(4):W354; author reply W355. doi: 10.2214/AJR.08.2194. AJR Am J Roentgenol. 2009. PMID: 19770307 No abstract available.

3

High signal intensity in dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in three patients with impaired renal function and vascular calcification.

Barbieri S, Schroeder C, Froehlich JM, Pasch A, Thoeny HC. Barbieri S, et al. Contrast Media Mol Imaging. 2016 May;11(3):245-50. doi: 10.1002/cmmi.1683. Epub 2016 Jan 11. Contrast Media Mol Imaging. 2016. PMID: 26929131 Free PMC article.

4

[Nephrogenic systemic fibrosis: a severe complication of use to gadolinium in patients with kidney failure].

Mundim JS, Lorena Sde C, Abensur H, Elias RM, Moysés RM, Castro MC, Romão Júnior JE. Mundim JS, et al. Rev Assoc Med Bras (1992). 2009 Mar-Apr;55(2):220-5. doi: 10.1590/s0104-42302009000200030. Rev Assoc Med Bras (1992). 2009. PMID: 19488662 Free article. Review. Portuguese.

5

Gadolinium-based contrast agents in children.

Rozenfeld MN, Podberesky DJ. Rozenfeld MN, et al. Pediatr Radiol. 2018 Aug;48(9):1188-1196. doi: 10.1007/s00247-018-4165-1. Epub 2018 Aug 4. Pediatr Radiol. 2018. PMID: 30078039 Review.

6

Gadolinium-associated nephrogenic systemic fibrosis.

Schlaudecker JD, Bernheisel CR. Schlaudecker JD, et al. Am Fam Physician. 2009 Oct 1;80(7):711-4. Am Fam Physician. 2009. PMID: 19817341 Free article.

7

Gadolinium-associated nephrogenic systemic fibrosis in patients with renal failure: the need for an interdisciplinary helping network.

Stratta P, Canavese C, Quaglia M, Fenoglio R. Stratta P, et al. Rheumatology (Oxford). 2010 Apr;49(4):821-3. doi: 10.1093/rheumatology/kep403. Epub 2009 Dec 23. Rheumatology (Oxford). 2010. PMID: 20032228 No abstract available.

8

Renal function, nephrogenic systemic fibrosis and other adverse reactions associated with gadolinium-based contrast media.

Canga A, Kislikova M, Martínez-Gálvez M, Arias M, Fraga-Rivas P, Poyatos C, de Francisco AL. Canga A, et al. Nefrologia. 2014;34(4):428-38. doi: 10.3265/Nefrologia.pre2014.Apr.12375. Nefrologia. 2014. PMID: 25036056 Free article. Review. English, Spanish.

9

Contemporary applications and limitations of magnetic resonance imaging contrast materials.

Natalin RA, Prince MR, Grossman ME, Silvers D, Landman J. Natalin RA, et al. J Urol. 2010 Jan;183(1):27-33. doi: 10.1016/j.juro.2009.09.029. J Urol. 2010. PMID: 19913804 Review.

10

Nephrogenic systemic fibrosis and gadolinium-based contrast agents.

Abu-Alfa AK. Abu-Alfa AK. Adv Chronic Kidney Dis. 2011 May;18(3):188-98. doi: 10.1053/j.ackd.2011.03.001. Adv Chronic Kidney Dis. 2011. PMID: 21531325 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

143 results

Results by year